REPROCELL Corporate News

Corporate News tagged:

Human Tissue Testing

REPROCELL supports Silo Pharma with successful human tissue testing in Rheumatoid Arthritis study

24 October 2023

REPROCELL supports Silo Pharma research success, investigating the effects of SPU-21 Peptide on rheumatoid arthritis in a human synovial tissue study

1

Stem cell and drug discovery scientists around the world use our services and products in their preclinical and clinical research.

 About REPROCELL

Corporate news by tag

  1. 3D Cell Culture
  2. Clinical Capabilities
  3. Drug Discovery
  4. Genomic services
  5. GMP
  6. Human Tissue Samples
  7. Human Tissue Testing
  8. Life Sciences
  9. Master Cell Banks
  10. Precision Medicine
  11. Product Catalog
  12. Regenerative Medicine
  13. Stem Cells
  14. Volunteer Registry

 Corporate news archive